Patient Selection
Good outcomes with light-based therapy begin with selecting the right patient and matching the modality to the disease in front of you. This page outlines the principles; the device Instructions for Use and clinical judgement govern the specifics.
Match the modality to the driver profile
The driver-based subclassification is the practical guide. For the broad, multi-driver dry eye that most patients have, spanning tear-film, lid and surface drivers, LM™ LLLT (PBM) is the primary choice, because it acts across all three groups. For milder, predominantly aqueous or surface-driven presentations, LLLT alone is often all that is warranted.
When to add IPL
The patient who benefits most from adding OPE™ IPL is typically one with significant meibomian gland dysfunction, visible lid-margin inflammation or telangiectasia, features of ocular rosacea, and an inadequate response to LLLT or lid-based measures alone. IPL is an adjunct for these lid-driven, inflammatory cases rather than a default partner.
Screening considerations
LLLT has a favourable profile with no absolute contraindications identified, which makes it suitable for a wide range of patients, including those on multiple medications. IPL is more conditional: a history of photosensitivity reactions and the use of photosensitising medications matter. The familiar example is a patient on doxycycline, where it may be prudent to hold IPL and proceed with LLLT alone. Where IPL is appropriate, documenting medications and confirming no photosensitivity history are part of good practice. See safety and tolerability.
The signs-without-symptoms patient
Not every candidate is symptomatic. The pre-surgical population often has signs without symptoms, where the goal is to optimise the surface so the patient does not develop dry eye after a procedure. DEWS III explicitly recognises this group (TFOS DEWS III, 2025, American Journal of Ophthalmology).
Shared decision-making
Selection is completed with the patient, through informed consent and a discussion of expectations, the course of treatment and the role of any home maintenance. The plan is individual, and treatments are used within their cleared indications.
Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.